Zealand Pharma A/S (ZEAL) — Net Asset Momentum
Zealand Pharma A/S (ZEAL) recorded a net asset momentum of 72.1% as of December 2025, with net assets of Dkr14.83 Billion DKK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Zealand Pharma A/S defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Zealand Pharma A/S Net Asset Momentum (2007–2025)
This chart tracks Zealand Pharma A/S's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is +72.1%, with net assets of Dkr14.83 Billion DKK as of December 2025. Read ZEAL current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Zealand Pharma A/S (2007–2025)
The table below shows the complete annual net asset history for Zealand Pharma A/S from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Zealand Pharma A/S.
| Year | Net Assets (DKK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Dkr14.83 Billion | Dkr16.46 Billion | Dkr1.63 Billion | ▲ +72.1% |
| 2024 | Dkr8.62 Billion | Dkr9.51 Billion | Dkr888.86 Million | ▲ +441.0% |
| 2023 | Dkr1.59 Billion | Dkr1.98 Billion | Dkr387.15 Million | ▲ +95.2% |
| 2022 | Dkr815.91 Million | Dkr1.54 Billion | Dkr723.89 Million | ▼ -12.1% |
| 2021 | Dkr927.80 Million | Dkr2.07 Billion | Dkr1.14 Billion | ▼ -21.2% |
| 2020 | Dkr1.18 Billion | Dkr1.92 Billion | Dkr747.52 Million | ▼ -5.3% |
| 2019 | Dkr1.24 Billion | Dkr1.60 Billion | Dkr356.84 Million | ▲ +11.3% |
| 2018 | Dkr1.12 Billion | Dkr1.23 Billion | Dkr113.52 Million | ▲ +111.2% |
| 2017 | Dkr528.47 Million | Dkr737.24 Million | Dkr208.77 Million | ▲ +90.0% |
| 2016 | Dkr278.19 Million | Dkr694.63 Million | Dkr416.43 Million | ▲ +10.3% |
| 2015 | Dkr252.23 Million | Dkr634.69 Million | Dkr382.46 Million | ▼ -0.2% |
| 2014 | Dkr252.83 Million | Dkr596.76 Million | Dkr343.93 Million | ▼ -20.0% |
| 2013 | Dkr316.14 Million | Dkr346.91 Million | Dkr30.77 Million | ▼ -35.6% |
| 2012 | Dkr491.01 Million | Dkr522.40 Million | Dkr31.39 Million | ▲ +11.2% |
| 2011 | Dkr441.40 Million | Dkr469.48 Million | Dkr28.08 Million | ▲ +8.4% |
| 2010 | Dkr407.11 Million | Dkr450.55 Million | Dkr43.44 Million | ▲ +206.3% |
| 2009 | Dkr132.92 Million | Dkr158.68 Million | Dkr25.75 Million | ▼ -36.3% |
| 2008 | Dkr208.63 Million | Dkr225.24 Million | Dkr16.61 Million | ▼ -13.9% |
| 2007 | Dkr242.37 Million | Dkr263.37 Million | Dkr21.00 Million | — |